Paroxysmal slow wave events predict epilepsy following a first seizure.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
01 2022
Historique:
revised: 14 10 2021
received: 28 07 2021
accepted: 14 10 2021
pubmed: 10 11 2021
medline: 21 4 2022
entrez: 9 11 2021
Statut: ppublish

Résumé

Management of a patient presenting with a first seizure depends on the risk of additional seizures. In clinical practice, the recurrence risk is estimated by the treating physician using the neurological examination, brain imaging, a thorough history for risk factors, and routine scalp electroencephalogram (EEG) to detect abnormal epileptiform activity. The decision to use antiseizure medication can be challenging when objective findings are missing. There is a need for new biomarkers to better diagnose epilepsy following a first seizure. Recently, an EEG-based novel analytical method was reported to detect paroxysmal slowing in the cortical network of patients with epilepsy. The aim of our study is to test this method's sensitivity and specificity to predict epilepsy following a first seizure. We analyzed interictal EEGs of 70 patients admitted to the emergency department of a tertiary referral center after a first seizure. Clinical data from a follow-up period of at least 18 months were available. EEGs of 30 healthy controls were also analyzed and included. For each EEG, we applied an automated algorithm to detect paroxysmal slow wave events (PSWEs). Of patients presenting with a first seizure, 40% had at least one additional recurring seizure and were diagnosed with epilepsy. Sixty percent did not report additional seizures. A significantly higher occurrence of PSWEs was detected in the first interictal EEG test of those patients who were eventually diagnosed with epilepsy. Conducting the EEG test within 72 h after the first seizure significantly increased the likelihood of detecting PSWEs and the predictive value for epilepsy up to 82%. The quantification of PSWEs by an automated algorithm can predict epilepsy and help the neurologist in evaluating a patient with a first seizure.

Identifiants

pubmed: 34750812
doi: 10.1111/epi.17110
pmc: PMC9298770
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-198

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© 2021 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Epilepsia Open. 2018 Sep 17;3(Suppl Suppl 2):120-126
pubmed: 30564770
Lancet. 1984 Apr 14;1(8381):837-9
pubmed: 6143148
J Clin Neurophysiol. 2009 Apr;26(2):123-8
pubmed: 19279502
Epilepsia. 2022 Jan;63(1):190-198
pubmed: 34750812
Neurosci Res. 2020 Jul;156:95-101
pubmed: 32045575
Epilepsia. 2009 May;50(5):1102-8
pubmed: 19374657
J Neurol. 2016 Dec;263(12):2386-2394
pubmed: 27604619
BMJ Open. 2017 Jul 13;7(7):e015696
pubmed: 28706099
Sci Transl Med. 2019 Dec 4;11(521):
pubmed: 31801888
Continuum (Minneap Minn). 2016 Feb;22(1 Epilepsy):38-50
pubmed: 26844729
Clin Electroencephalogr. 2003 Jul;34(3):140-4
pubmed: 14521275
J Immunol. 2015 Aug 15;195(4):1713-22
pubmed: 26136430
Neurology. 2007 Apr 10;68(15):1188-96
pubmed: 17420402
Epilepsia. 2011 Mar;52(3):467-76
pubmed: 21204828
Biochem Med (Zagreb). 2016 Oct 15;26(3):297-307
pubmed: 27812299
Prog Neurobiol. 2012 Sep;98(3):302-15
pubmed: 22480752
Ann Neurol. 2021 Jan;89(1):134-142
pubmed: 33070359
Neurobiol Dis. 2015 Jun;78:115-25
pubmed: 25836421
J Neurosci. 2017 Apr 26;37(17):4450-4461
pubmed: 28330876
Seizure. 2017 Jul;49:69-73
pubmed: 28532713
Lancet Neurol. 2016 Jul;15(8):843-856
pubmed: 27302363
Eur J Neurol. 2016 Mar;23(3):455-63
pubmed: 26073548
Front Hum Neurosci. 2021 Jul 30;15:709836
pubmed: 34393743
J Neurosci. 2004 Sep 8;24(36):7829-36
pubmed: 15356194

Auteurs

Daniel Zelig (D)

Departments of Physiology and Cell Biology, Cognitive, and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ilan Goldberg (I)

Department of Neurology, Rabin Medical Center, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Oded Shor (O)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Felsenstein Medical Research Center, Beilinson Hospital, Petach Tikva, Israel.

Shira Ben Dor (S)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Amit Yaniv-Rosenfeld (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dan Z Milikovsky (DZ)

Departments of Physiology and Cell Biology, Cognitive, and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Jonathan Ofer (J)

Departments of Physiology and Cell Biology, Cognitive, and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Hamza Imtiaz (H)

Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.

Alon Friedman (A)

Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.

Felix Benninger (F)

Department of Neurology, Rabin Medical Center, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Felsenstein Medical Research Center, Beilinson Hospital, Petach Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH